Grant: Discovery Grants Program - Individual
University of British Columbia
$28,000.00
Coupling and rearrangement reactions in the biosynthesis of bis-heterocyclic natural products
FY 2012-13
Summary
There is an urgent need for new antibiotic and anticancer agents. One important route to generate new drug molecules is to engineer biosynthetic pathways to existing molecules to create derivatives with improved pharmacological properties. Bacteria are a rich source for such drug molecules and biosynthetic pathways. The clustering of biosynthetic genes in their genomes enables a variety of studies: facile identification of new gene clusters, heterologous expression of entire pathways, and rapid engineering to generate new biosynthetic derivatives. This grant is focused on the biosynthetic pathways to bis-heterocyclic molecules, a group of compounds containing two dimerized, heterocyclic monomers in their structures. Little is known about the mechanisms that lead to the production of such molecules. The objective of this program is to characterize the biosynthetic pathways and key biosynthetic enzymes to two important bis-heterocyclic molecules. My hypothesis is that these two molecules are derived from enzymatic coupling and rearrangement reactions that fuse and contort well-studied heterocyclic monomers into unusual, dimerized molecular skeletons. This hypothesis will be tested by identifying the gene cluster responsible for the production of each molecule and carrying out genetic experiments to test the roles of individual biosynthetic genes. Further, we will biochemically and structurally characterize key enzymes in each pathway. Our proposed biosynthetic studies are significant because they will provide the necessary data and materials to enable studies to generate libraries of structurally related derivatives of these drug molecules. The proposed research is innovative because it focuses on the enzymatic basis for the dimerization and rearrangement of heterocyclic monomers to give bis-heterocyclic natural products and will provide new knowledge about how nature constructs this class of molecules.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
402631-2011
Name nom
Ryan, Katherine
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
2
Nb partie
5
Application title
Coupling and rearrangement reactions in the biosynthesis of bis-heterocyclic natural products
Keyword
NSERC
Application summary
There is an urgent need for new antibiotic and anticancer agents. One important route to generate new drug molecules is to engineer biosynthetic pathways to existing molecules to create derivatives with improved pharmacological properties. Bacteria are a rich source for such drug molecules and biosynthetic pathways. The clustering of biosynthetic genes in their genomes enables a variety of studies: facile identification of new gene clusters, heterologous expression of entire pathways, and rapid engineering to generate new biosynthetic derivatives. This grant is focused on the biosynthetic pathways to bis-heterocyclic molecules, a group of compounds containing two dimerized, heterocyclic monomers in their structures. Little is known about the mechanisms that lead to the production of such molecules. The objective of this program is to characterize the biosynthetic pathways and key biosynthetic enzymes to two important bis-heterocyclic molecules. My hypothesis is that these two molecules are derived from enzymatic coupling and rearrangement reactions that fuse and contort well-studied heterocyclic monomers into unusual, dimerized molecular skeletons. This hypothesis will be tested by identifying the gene cluster responsible for the production of each molecule and carrying out genetic experiments to test the roles of individual biosynthetic genes. Further, we will biochemically and structurally characterize key enzymes in each pathway. Our proposed biosynthetic studies are significant because they will provide the necessary data and materials to enable studies to generate libraries of structurally related derivatives of these drug molecules. The proposed research is innovative because it focuses on the enzymatic basis for the dimerization and rearrangement of heterocyclic monomers to give bis-heterocyclic natural products and will provide new knowledge about how nature constructs this class of molecules.